Elanco Animal Health Incorporated Shares Outstanding (Cover Page)
Elanco Animal Health Incorporated (ELAN) had Shares Outstanding (Cover Page) of 499.62 million shares as of 2026-08-03, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-08-03: Entity Common Stock, Shares Outstanding 499.62M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 499.45M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 497.17M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 496.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 499.62M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 499.45M shares 10-Q · filed 2026-05-06 |
| 2026-02-19 | 497.17M shares 10-K · filed 2026-02-24 |
| 2025-10-31 | 496.86M shares 10-Q · filed 2025-11-05 |
| 2025-08-04 | 496.81M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 496.65M shares 10-Q · filed 2025-05-07 |
| 2025-02-20 | 494.61M shares 10-K · filed 2025-02-25 |
| 2024-11-04 | 494.35M shares 10-Q · filed 2024-11-07 |
| 2024-08-05 | 494.33M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 494.18M shares 10-Q · filed 2024-05-08 |
| 2024-02-21 | 492.97M shares 10-K · filed 2024-02-26 |
| 2023-11-02 | 492.80M shares 10-Q · filed 2023-11-07 |
| 2023-08-03 | 492.68M shares 10-Q · filed 2023-08-07 |
| 2023-05-04 | 492.55M shares 10-Q · filed 2023-05-09 |
| 2023-02-24 | 491.54M shares 10-K · filed 2023-03-01 |
| 2022-11-03 | 474.21M shares 10-Q · filed 2022-11-08 |
| 2022-08-03 | 474.11M shares 10-Q · filed 2022-08-08 |
| 2022-05-04 | 474.10M shares 10-Q · filed 2022-05-09 |
| 2022-02-23 | 473.19M shares 10-K · filed 2022-02-28 |
| 2021-11-01 | 473.10M shares 10-Q · filed 2021-11-05 |
| 2021-08-05 | 473.02M shares 10-Q · filed 2021-08-09 |
| 2021-05-03 | 473.00M shares 10-Q · filed 2021-05-07 |
| 2021-02-24 | 472.17M shares 10-K · filed 2021-03-01 |
| 2020-11-02 | 471.92M shares 10-Q · filed 2020-11-06 |
| 2020-07-27 | 398.90M shares 10-Q · filed 2020-07-30 |
| 2020-05-04 | 398.89M shares 10-Q · filed 2020-05-07 |
| 2020-02-25 | 398.53M shares 10-K · filed 2020-02-28 |
| 2019-11-06 | 373.00M shares 10-Q · filed 2019-11-08 |
| 2019-08-09 | 373.00M shares 10-Q · filed 2019-08-13 |
| 2019-05-10 | 365.71M shares 10-Q · filed 2019-05-14 |
| 2019-02-18 | 365.64M shares 10-K · filed 2019-02-20 |
| 2018-11-06 | 365.63M shares 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |